Trial Profile
An Observational Cohort Study of the Risk of Thromboembolic Events Among Adult Patients Treated With KCENTRA Compared With Plasma for Urgent Reversal of Vitamin K Antagonist Therapy in the Setting of Acute Major Bleeding
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2021
Price :
$35
*
At a glance
- Drugs Prothrombin complex concentrate (Primary) ; Plasma
- Indications Haemorrhage
- Focus Adverse reactions
- Sponsors CSL Behring
- 24 May 2021 Status changed from recruiting to completed.
- 21 Apr 2020 Planned End Date changed from 1 Jun 2020 to 15 Mar 2023.
- 21 Apr 2020 Planned primary completion date changed from 1 Jun 2020 to 15 Mar 2023.